RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity

Go back to RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity

Amgen (AMGN) Volatile as AMG145 Said to Significantly Lower LDL Levels

November 5, 2012 2:03 PM EST

Amgen, Inc. (Nasdaq: AMGN) is higher amid a Reuters report that its AMD145 cuts LDL cholesterol by a "considerable amount." LDL was trimmed by as much as 55 percent in combo with statin drugs in patients which are genetically predispositioned to higher... More